ArticleJournal of personalized medicine2022

Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective Analysis.

Andrea Becciolini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.